2 results
Approved WMOWill not start
The primary objective of the study is:Evaluate the safety of 6.0 mg/kg and 12 mg/kg SM101 per week in SLE patients with or without a history of lupus nephritis.The Secondary objective is:Evaluate the efficacy and pharmacokinetics (PK) of 6.0 mg/kg…
Approved WMOCompleted
Primary Objective:To assess the efficacy potential of GSK3196165 on pain in inflammatory HOA.Secondary endpoints:To evaluate impact of GSK3196165 on average and worst HOA pain, over time.To assess the impact of GSK3196165 on hand pain (on use),…